- September 08, 2023
AI More Accurately Identifies Patients With Advanced Lung Cancer Who Respond to Immunotherapy
- September 08, 2023
New Immunotherapy Treatment Brings Hope to Patients With Advanced Non-Small Cell Lung Cancer
- August 11, 2023
Study Shows Promise of Immunotherapy Treatment for Penile Cancer
- August 07, 2023
Screening Mammograms Carry Risks for Older Women, Study Finds
- August 03, 2023Source: YaleNews
Method Allows New Insights Into Interplay Between Immune System and Tumors
- July 31, 2023
Researchers Develop a New Way to Classify HPV-Associated Head and Neck Cancers
- July 27, 2023
Yale Scientists Identify Immune Cells Critical for Immunologic Memory for Melanoma
- July 27, 2023Source: YaleNews
Taming the Self-Destructive Tendencies of Killer T Cells Used to Treat Cancer
- July 12, 2023
Combination Therapies Benefit Patients With Advanced Non-Small Cell Lung Cancer
- July 06, 2023Source: YaleNews
Eliminating Extra Chromosomes in Cancer Cells Prevents Tumor Growth
- June 30, 2023
Pancreatic Cancer Risk Lower if Cysts Remain Stable for Five Years
- June 21, 2023
Study Hints at How Cancer Immunotherapy Can Be Safer
- May 31, 2023
Impact of Changing Landscape for Patients With Cancer Who Are Prescribed Opioids
- May 15, 2023
Study Identifies Bereaved Parents’ Medical Priorities for Children With Advanced Cancer
- March 07, 2023Source: YaleNews
Bosenberg Named Brady Professor of Dermatology, Pathology, and Immunobiology
- January 31, 2023
Trial Shows Significant Disease-free Survival for Patients Diagnosed With Non-small Cell Lung Cancer
- January 31, 2023
Study Finds Large Gap in Breast Cancer Treatment Recommendations for Patients Aged 70 vs 69
- January 25, 2023
Older Patients Left Behind in Progress Against Lung Cancer, Yale Study Shows
- January 25, 2023
Yale Scientists Enable Massively Parallel DNA Insertions Into Human Cells
- December 15, 2022Source: Yale SEAS
With Discovery, Oxygen's Role in Growth of Tumors Reconsidered
Cancer
Yale Cancer Center embraces a tradition of innovative cancer treatment and quality care. A National Cancer Institute (NCI) designated comprehensive cancer center for over 45 years, Yale Cancer Center is one of only 51 such centers in the United States. Cancer care is available to patients and families through Smilow Cancer Hospital and the Smilow Cancer Hospital Network through multidisciplinary teams who work together to make sure that every aspect of a patient’s treatment plan is personalized and well managed. Smilow Cancer Hospital is accredited by the Commission on Cancer, a Quality program of the American College of Surgeons, and recognized by the American Society of Clinical Oncology with a Quality Oncology Practice Initiative (QOPI) certification.
A world leader in cancer care, research, and education, Yale Cancer Center delivers the transformative scientific discoveries and care innovations of Smilow Cancer Hospital and Yale School of Medicine to bring us closer to a world free of cancer–one patient at a time. Recent advances in immunotherapy to treat certain cancers have been transformational, and Yale Cancer Center and Smilow Cancer Hospital are leaders in the cancer immunotherapy revolution.
Members of six cancer research programs led 793 scientific publications in 2021, generating new data, new discussions, and new outcomes to meaningfully improve the course of cancer care. The collaborations between Yale Cancer Center’s research programs and Smilow Cancer Hospital’s clinical centers are advancing innovations from laboratories to benefit patients while, at the same time, bringing data back to inform future laboratory discoveries. Over the next five years, this momentum will strengthen, further positioning Yale Cancer Center and Smilow Cancer Hospital as national and international leaders in cancer research and care, while also tackling issues of disparities and inequities in our community.
If we pay attention to our patients, we learn so much about what to pursue in our research and how to provide the care in clinic. We can provide the best care today and learn how to make it ever so much better in the future—that’s what drives me to build an even stronger cancer center and programs at Smilow that focus on patient experience.